DBV Technologies S.A. Company Profile (NASDAQ:DBVT)

About DBV Technologies S.A.

DBV Technologies S.A. logoDBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DBVT
  • CUSIP:
Key Metrics:
  • Previous Close: $36.17
  • 50 Day Moving Average: $34.66
  • 200 Day Moving Average: $35.40
  • 52-Week Range: $46,000,000.00 - $24.94
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.95
  • P/E Growth: -0.30
  • Market Cap: $1.65B
  • Outstanding Shares: 46,000,000
  • Beta: 1.47
Additional Links:
Companies Related to DBV Technologies S.A.:

Analyst Ratings

Consensus Ratings for DBV Technologies S.A. (NASDAQ:DBVT) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $47.75 (33.45% upside)

Analysts' Ratings History for DBV Technologies S.A. (NASDAQ:DBVT)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017NatixisUpgradeNeutral -> BuyView Rating Details
10/24/2016Jefferies Group LLCSet Price TargetBuy$47.00View Rating Details
9/26/2016JMP SecuritiesInitiated CoverageOutperform$47.00View Rating Details
8/23/2016Leerink SwannReiterated RatingBuy$54.00View Rating Details
3/16/2016Citigroup Inc.Lower Price TargetBuy$48.00 -> $43.00View Rating Details
3/7/2016HC WainwrightReiterated RatingBuyView Rating Details
12/3/2015Barclays PLCInitiated CoveragePositive -> Overweight$58.00View Rating Details
10/23/2015Bank of America CorpInitiated CoverageBuy$48.00View Rating Details
9/15/2015Morgan StanleyInitiated CoverageOverweight$59.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for DBV Technologies S.A. (NASDAQ:DBVT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/26/2015($0.44)($0.79)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DBV Technologies S.A. (NASDAQ:DBVT)
Current Year EPS Consensus Estimate: $-4.34 EPS
Next Year EPS Consensus Estimate: $-5.15 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.70)($0.70)($0.70)
Q4 20161($0.76)($0.76)($0.76)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DBV Technologies S.A. (NASDAQ:DBVT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for DBV Technologies S.A. (NASDAQ:DBVT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for DBV Technologies S.A. (NASDAQ:DBVT)
DateHeadline
finance.yahoo.com logoDBV Technologies Reports December 31, 2016 Cash Position (NASDAQ:DBVT)
finance.yahoo.com - February 20 at 11:34 AM
finance.yahoo.com logoDBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT® (NASDAQ:DBVT)
finance.yahoo.com - February 18 at 8:25 AM
us.rd.yahoo.com logo3:10 am DBV Technologies completes enrollment of Phase IIA study of Viaskin Milk; expects results in 1H18 (NASDAQ:DBVT)
us.rd.yahoo.com - February 3 at 10:03 PM
finance.yahoo.com logoDBV Technologies Announces Financial Calendar 2017 (NASDAQ:DBVT)
finance.yahoo.com - January 9 at 2:37 AM
finance.yahoo.com logoDBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company (NASDAQ:DBVT)
finance.yahoo.com - January 4 at 5:44 PM
finance.yahoo.com logoDBV Technologies presents its Half-year Statement of the Liquidity Contract (NASDAQ:DBVT)
finance.yahoo.com - January 4 at 5:44 PM
investornewswire.com logoDBV Technologies S.A. (NASDAQ:DBVT) Strong Buy Recommendations At 5 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - December 31 at 3:05 AM
News IconTrading Indicator Check on Dbv Technologies S.A. (DBVT) - StockTalk Daily (NASDAQ:DBVT)
stocktalkdaily.com - December 9 at 10:00 PM
finance.yahoo.com logoDBV Technologies :Monthly information regarding the total number of voting rights and total number of shares of the Company (NASDAQ:DBVT)
finance.yahoo.com - December 7 at 3:53 PM
finance.yahoo.com logoLysogene Appoints David Schilansky to Board of Directors (NASDAQ:DBVT)
finance.yahoo.com - December 7 at 9:47 AM
us.rd.yahoo.com logoDBV Technologies SA – ADR (DBVT): Smart Money Is Slowly Coming Back (NASDAQ:DBVT)
us.rd.yahoo.com - December 5 at 12:06 PM
investornewswire.com logoBuy Calls Of DBV Technologies S.A. (NASDAQ:DBVT) At 1 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - December 2 at 4:58 PM
nasdaq.com logoIs DBV Technologies (DBVT) Stock a Solid Choice Right Now? - Nasdaq (NASDAQ:DBVT)
www.nasdaq.com - December 2 at 4:58 PM
News IconIs DBV Technologies (DBVT) Stock a Solid Choice Right Now? - Yahoo Sports (NASDAQ:DBVT)
sports.yahoo.com - December 1 at 4:47 PM
finance.yahoo.com logoIs DBV Technologies (DBVT) Stock a Solid Choice Right Now? (NASDAQ:DBVT)
finance.yahoo.com - December 1 at 4:47 PM
News IconDBV Technologies S.A. (NASDAQ:DBVT) Under Analyst Spotlight - UK Market News (NASDAQ:DBVT)
www.ukmarketnews.co.uk - November 30 at 8:06 AM
News IconEquity Focus: Indicator Check on Shares of Dbv Technologies S.A. (DBVT) - StockTalk Daily (NASDAQ:DBVT)
stocktalkdaily.com - November 20 at 4:29 PM
finance.yahoo.com logoDBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis (NASDAQ:DBVT)
finance.yahoo.com - November 20 at 8:43 AM
investornewswire.com logoCan Shares Of DBV Technologies S.A. (NASDAQ:DBVT) Smash $64? - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - November 18 at 8:25 PM
streetinsider.com logoForm 6-K DBV Technologies SA For: Nov 17 - StreetInsider.com (NASDAQ:DBVT)
www.streetinsider.com - November 17 at 3:50 PM
finance.yahoo.com logoDBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting (NASDAQ:DBVT)
finance.yahoo.com - November 11 at 9:49 PM
investornewswire.com logoCan Shares Of DBV Technologies S.A. (NASDAQ:DBVT) Get To $64? - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - November 11 at 3:53 PM
News IconBlog Coverage DBV Technologies Executes Phase II Study of VIASKIN Milk for Treatment of Milk Allergic Patients - Yahoo Sports (NASDAQ:DBVT)
sports.yahoo.com - November 10 at 1:07 PM
publicnow.com logoDBV Technologies to Attend Upcoming Investor Conferences (NASDAQ:DBVT)
www.publicnow.com - November 10 at 1:07 PM
finance.yahoo.com logoBlog Coverage DBV Technologies Executes Phase II Study of VIASKIN Milk for Treatment of Milk Allergic Patients (NASDAQ:DBVT)
finance.yahoo.com - November 9 at 1:46 PM
streetinsider.com logoForm 6-K DBV Technologies SA For: Nov 08 - StreetInsider.com (NASDAQ:DBVT)
www.streetinsider.com - November 8 at 10:57 AM
publicnow.com logoDBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients (NASDAQ:DBVT)
www.publicnow.com - November 8 at 10:57 AM
investornewswire.com logoCan Shares Of DBV Technologies S.A. (NASDAQ:DBVT) Hit $64? - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - November 5 at 4:40 PM
News IconAnalyst Coverage: DBV Technologies S.A. (NASDAQ:DBVT) - NewsDen (NASDAQ:DBVT)
newsden.net - November 5 at 4:40 PM
streetinsider.com logoForm 6-K DBV Technologies SA For: Nov 03 - StreetInsider.com (NASDAQ:DBVT)
www.streetinsider.com - November 4 at 11:53 AM
publicnow.com logoDBV Technologies Reports September 30, 2016 Cash Position (NASDAQ:DBVT)
www.publicnow.com - November 3 at 7:58 AM
finance.yahoo.com logoThere's a patch that could fix your peanut allergy problem (NASDAQ:DBVT)
finance.yahoo.com - November 1 at 4:46 PM
investornewswire.com logoDBV Technologies S.A. (NASDAQ:DBVT) Buy Calls At 1 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - October 28 at 9:25 PM
finance.yahoo.com logoDBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology (NASDAQ:DBVT)
finance.yahoo.com - October 26 at 4:38 PM
finance.yahoo.com logoDBV Technologies: Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut (NASDAQ:DBVT)
finance.yahoo.com - October 25 at 9:25 AM
finance.yahoo.com logo4:32 pm DBV Technologies announces topline results from the two-year OLFUS-VIPES study supporting the durable effect and favorable safety profile of Viaskin Peanut for the treatment of peanut-allergic children (NASDAQ:DBVT)
finance.yahoo.com - October 25 at 9:25 AM
publicnow.com logoTopline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut (NASDAQ:DBVT)
www.publicnow.com - October 25 at 9:25 AM
investornewswire.com logoSell Recommendations For DBV Technologies S.A. (NASDAQ:DBVT) At 0 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - October 22 at 4:23 PM
News IconHitting the Skids Pre-Market With A Gap Down: DBV Technologies S.A. (NASDAQ:DBVT) - CSZ News (NASDAQ:DBVT)
cincysportszone.com - October 20 at 10:02 AM
News IconDBV Technologies S.A. (NASDAQ:DBVT) Updated Analyst Coverage - NewsDen (NASDAQ:DBVT)
newsden.net - October 18 at 4:31 PM
investornewswire.com logoDBV Technologies S.A. (NASDAQ:DBVT) Sell Calls At 0 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - October 15 at 9:23 AM
News IconUpgrades And Downgrades For DBV Technologies S.A. (NASDAQ:DBVT) - NewsDen (NASDAQ:DBVT)
newsden.net - October 8 at 4:24 PM
investornewswire.com logoDBV Technologies S.A. (NASDAQ:DBVT) Sell Recommendations At 0 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - October 8 at 9:17 AM
investornewswire.com logoCan Shares Of DBV Technologies S.A. (NASDAQ:DBVT) Hit $63? - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - October 1 at 10:02 AM
finance.yahoo.com logoCoverage initiated on DBV Technologies by JMP Securities (NASDAQ:DBVT)
finance.yahoo.com - September 26 at 4:46 PM
publicnow.com logoDBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy (NASDAQ:DBVT)
www.publicnow.com - September 21 at 8:52 AM
publicnow.com logoMonthly information regarding the total number of voting rights and total number of shares of the Company (NASDAQ:DBVT)
www.publicnow.com - September 12 at 9:29 AM
publicnow.com logoDBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination (NASDAQ:DBVT)
www.publicnow.com - September 6 at 9:26 AM
publicnow.com logoDBV Technologies Announces Expansion of Clinical Program of Viaskin Peanut for the Treatment of Peanut Allergy (NASDAQ:DBVT)
www.publicnow.com - August 2 at 9:21 AM
publicnow.com logoFirst Half of 2016 Condensed Consolidated Financial Statements (NASDAQ:DBVT)
www.publicnow.com - July 28 at 5:08 AM

Social

What is DBV Technologies S.A.'s stock symbol?

DBV Technologies S.A. trades on the NASDAQ under the ticker symbol "DBVT."

Where is DBV Technologies S.A.'s stock going? Where will DBV Technologies S.A.'s stock price be in 2017?

6 analysts have issued 12-month target prices for DBV Technologies S.A.'s stock. Their forecasts range from $43.00 to $54.00. On average, they anticipate DBV Technologies S.A.'s share price to reach $47.75 in the next twelve months.

Who owns DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (8.80%), Janus Capital Management LLC (5.51%), Deerfield Management Co. (3.79%), Arrowpoint Asset Management LLC (1.81%), Perceptive Advisors LLC (1.33%) and Artisan Partners Limited Partnership (1.09%).

Who sold DBV Technologies S.A. stock? Who is selling DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, FMR LLC and Artisan Partners Limited Partnership.

Who bought DBV Technologies S.A. stock? Who is buying DBV Technologies S.A. stock?

DBV Technologies S.A.'s stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Arrowpoint Asset Management LLC, Acuta Capital Partners LLC and Castleark Management LLC.

How do I buy DBV Technologies S.A. stock?

Shares of DBV Technologies S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of DBV Technologies S.A. stock cost?

One share of DBV Technologies S.A. stock can currently be purchased for approximately $35.78.

DBV Technologies S.A. (NASDAQ:DBVT) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for DBV Technologies S.A. (NASDAQ:DBVT)

Earnings History Chart

Earnings by Quarter for DBV Technologies S.A. (NASDAQ:DBVT)

Dividend History Chart

Dividend Payments by Quarter for DBV Technologies S.A. (NASDAQ:DBVT)

Last Updated on 2/26/2017 by MarketBeat.com Staff